Article List

WPRIM Management System> DCMS> Chinese Journal of Lung Cancer> 2018> 21> 7

1. Apatinib as Salvage Therapy for Heavily Pretreated SCLC.	Page:565—570
2. Research Progress of Raman Spectroscopy in the Diagnosis of Early Lung Cancer.	Page:560—564
3. MET Exon 14 Skipping Mutations in Non-small Cell Lung Cancer.	Page:553—559
4. Research Progress of Lymph Node Micrometastasis in Non-small Cell Lung Cancer.	Page:547—552
5. Research Progress of Circular RNA in Lung Cancer.	Page:543—546
6. Association between EGFR, ALK and KRAS Gene Status and Synchronous Distant  Organ Metastasis in Non-small Cell Lung Cancer.	Page:536—542
7. Clinical Evaluation of A New Pathological Classification for  Non-small Cell Lung Cancer Based on Histogenesis of Bronchial Tree.	Page:530—535
8. Is 18F-PET-CT the First Choice for Preoperative Screening  for Ia Non-small Cell Lung Cancer?	Page:526—529
9. Correlation between Serum Cytokeratin 19 Fragment and the Clinicopathological Features and Prognosis of Thymic Epithelial Tumors.	Page:519—525
10. Efficacy and Safety of Bevacizumab Combined with Chemotherapy as Second-line or Later-line Treatment in Advanced Nonsquamous Non-small Cell Lung Cancer.	Page:513—518
11. Mechanism of EGFR Over-expression and Mutations Leading to  Biological Characteristics Changes of Human Lung Adenocarcinoma Cells  through CXCR4/CXCL12 Signaling Pathway.	Page:503—512